Roman Yelensky

Company: Gritstone Oncology
Job title: Chief Technology Officer
Seminars:
Neoantigen Targeted Cancer Immunotherapy in the Clinic 8:00 am
• Neoantigens are key tumor specific targets that may be targeted therapeutically • Neoantigens can be identified for each patient using NGS and machine learning • Immunoassays and ctDNA can be used to evaluate neoantigen immunotherapies in the clinicRead more
day: Day One